IDO1 and breast carcinoma: Through our investigations on IDO1 in breast cancer, as well as its well-established immunomodulatory characteristics and the advantages of machine learning (ML) methods, we hypothesized that H&E image features could be useful for IDO1 status and outcome prediction in breast cancer; this approach remains unexplored.